217 related articles for article (PubMed ID: 17012871)
1. Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
Halperin SA; Langley JM; Hesley TM; Zappacosta PS; Radley D; Smith B; Hoffenbach A; Boslego J; Silber JL
Hum Vaccin; 2005; 1(6):245-50. PubMed ID: 17012871
[TBL] [Abstract][Full Text] [Related]
2. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
[TBL] [Abstract][Full Text] [Related]
3. Disparate kinetics in immune response of two different
Martinón-Torres F; Salamanca de la Cueva I; Horn M; Westerholt S; Bosis S; Meyer N; Cheuvart B; Virk N; Jakes RW; Duchenne M; Van den Steen P
Hum Vaccin Immunother; 2024 Dec; 20(1):2342630. PubMed ID: 38687024
[TBL] [Abstract][Full Text] [Related]
4. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
Pichichero ME; Latiolais T; Bernstein DI; Hosbach P; Christian E; Vidor E; Meschievitz C; Daum RS
Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.
Lalwani SK; Agarkhedkar S; Sundaram B; Mahantashetti NS; Malshe N; Agarkhedkar S; Van Der Meeren O; Mehta S; Karkada N; Han HH; Mesaros N
Hum Vaccin Immunother; 2017 Jan; 13(1):120-127. PubMed ID: 27629913
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine.
Bégué P; Stagnara J; Vie-Le-Sage F; Bernard JC; Xerri B; Abitbol V
Pediatr Infect Dis J; 1997 Aug; 16(8):787-94. PubMed ID: 9271042
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence to diphtheria toxoid, tetanus toxoid,
Wanlapakorn N; Sarawanangkoor N; Srimuan D; Thatsanathorn T; Thongmee T; Poovorawan Y
Hum Vaccin Immunother; 2024 Dec; 20(1):2352909. PubMed ID: 38752802
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine.
Dagan R; Igbaria K; Piglansky L; Melamed R; Willems P; Grossi A; Kaufhold A
Pediatr Infect Dis J; 1997 Dec; 16(12):1113-21. PubMed ID: 9427455
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
[TBL] [Abstract][Full Text] [Related]
11. The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model.
Shams H; Heron I
APMIS; 1998 May; 106(5):526-34. PubMed ID: 9674889
[TBL] [Abstract][Full Text] [Related]
12. Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
Xu J; Stek JE; Ziani E; Liu GF; Lee AW
Pediatr Infect Dis J; 2019 Apr; 38(4):439-443. PubMed ID: 30882742
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age.
Mills E; Gold R; Thipphawong J; Barreto L; Guasparini R; Meekison W; Cunning L; Russell M; Harrison D; Boyd M; Xie F
Vaccine; 1998 Apr; 16(6):576-85. PubMed ID: 9569468
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age.
Gold R; Scheifele D; Barreto L; Wiltsey S; Bjornson G; Meekison W; Guasparini R; Medd L
Pediatr Infect Dis J; 1994 May; 13(5):348-55. PubMed ID: 8072815
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.
Schmitt HJ; Maechler G; Habermehl P; Knuf M; Saenger R; Begg N; Boutriau D
Clin Vaccine Immunol; 2007 Apr; 14(4):426-34. PubMed ID: 17287313
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study.
Dhingra MS; Namazova-Baranova L; Arredondo-Garcia JL; Kim KH; Limkittikul K; Jantarabenjakul W; Perminova O; Kobashi IAR; Bae CW; Ojeda J; Park J; Chansinghakul D; B'Chir S; Neveu D; Bonaparte M; Jordanov E
Epidemiol Infect; 2021 Apr; 149():e90. PubMed ID: 33814028
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile.
Hoppenbrouwers K; Lagos R; Swennen B; Ethevenaux C; Knops J; Levine MM; Desmyter J
Vaccine; 1998; 16(9-10):921-7. PubMed ID: 9682338
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study.
Nakano T; Hasegawa M; Endo M; Matsuda K; Tamai H
Vaccine; 2024 Apr; 42(12):3134-3143. PubMed ID: 38582691
[TBL] [Abstract][Full Text] [Related]
19. Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.
Espinoza F; Tregnaghi M; Gentile A; Abarca K; Casellas J; Collard A; Lefevre I; Jacquet JM
BMC Infect Dis; 2010 Oct; 10():297. PubMed ID: 20950456
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.
Capeding MR; Cadorna-Carlos J; Book-Montellano M; Ortiz E
Bull World Health Organ; 2008 Jun; 86(6):443-51. PubMed ID: 18568273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
